Autoimmune Diseases  >>  Enbrel (etanercept)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

7 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Enbrel (etanercept) / Pfizer, Amgen
NCT00520572 / 2007-001420-12: A 6-month Randomised, Double-blind, Open Arm Comparator, Phase IIb, With AZD9056, in Patients With Rheumatoid Arthritis (RA)

Completed
2b
385
US, Canada, Europe, RoW
AZD9056, Etanercept, Placebo
AstraZeneca
Rheumatoid Arthritis
 
03/09
ESCAPE, NCT00713544 / 2007-007539-14: A Proof of Concept and Dose Ranging Study in Patients With Rheumatoid Arthritis

Completed
2b
373
Europe, RoW
AZD5672, Etanercept, Enbrel, Placebo
AstraZeneca
Rheumatoid Arthritis
04/09
04/09
NCT00162279: The Study of Abatacept in Combination With Etanercept

Completed
2
141
US
Abatacept
Bristol-Myers Squibb
Rheumatoid Arthritis
02/07
02/07
NCT00298272: Safety and Tolerability of Rituxan With Methotrexate and Etanercept or Methotrexate and Adalimumab in Patients With Active Rheumatoid Arthritis

Terminated
2
54
US
IDEC-C2B8 (rituximab), Rituxan, Placebo, Methotrexate, Etanercept, Enbrel, Adalimumab, Humira, Methylprednisolone, Folate
Biogen, Hoffmann-La Roche, Genentech, Inc.
Rheumatoid Arthritis
04/09
07/11
NCT00979771: A Study to Investigate the Ability of GSK706769 to Maintain Clinical Remission After Withdrawal of Enbrel in Rheumatoid Arthritis Patients

Withdrawn
2
0
Europe
GSK706769, Placebo
GlaxoSmithKline
Arthritis, Rheumatoid
04/11
04/11
TARGET-DLE, NCT02656082 / 2015-001602-33: Targeted Therapy Using Intradermal Injection of Etanercept for Remission Induction in Discoid Lupus Erythematosus

Completed
2
25
Europe
Etanercept, Enbrel
University of Leeds, National Institute for Health Research, United Kingdom, Pfizer, Clinical Trials Research Unit, Leeds
Lupus Erythematosus, Discoid, Lupus Erythematosus, Cutaneous, Lupus Erythematosus, Chronic Cutaneous
12/17
12/17
NCT00285233: Delayed Mycophenolate Mofetil in Single-Donor Islet Allotransplantation in Type 1 Diabetes

Completed
1/2
8
US
Allogeneic islets of Langerhans transplant, Islet transplant
University of Minnesota, Roche Pharma AG, Juvenile Diabetes Research Foundation
Type 1 Diabetes, Hypoglycemia
09/04
03/05

Download Options